NANO-ENABLED PACKAGING FOR THE PHARMACEUTICAL INDUSTRY – A GLOBAL TECHNOLOGY, INDUSTRY AND MARKET ANALYSIS

REPORT SUMMARY http://www.innoresearch.net/report_summary.aspx?id=72&pg=93&rcd=PH-101&pd=3/1/2010 Packaging in the pharmaceutical industry has gone through major changes in the past decade. The advent of new drug delivery systems and the development of new biochemical compounds have resulted in a need not only for enhanced protection against factors such as moisture, light, oxygen and mechanical forces, but also for packaging forms to play a more integral role in the drug delivery process.  Nanotechnology is poised to have a big impact in pharmaceutical packaging and will enable it to bring innovative and new generation packaging solutions to market. The addition of certain nanoparticles into shaped objects and films has been shown to render them light, fire-resistant and stronger in terms of mechanical and thermal performance, as well as less permeable to gases. Thus, it is possible to make new packaging solutions that focus more on drug safety by controlling microbial growth and delaying oxidation as well as improving tamper visibility and anti-counterfeiting. As nanotechnology meets the new demands of pharma packaging, there are opportunities for tremendous growth in next few years. To clearly understand the landscape and undercurrents, the nano-enabled packaging for pharma industry has been segmented by: technology – active and smart packaging; pharma packaging applications – blisters, containers, bottles, pouches, syringes etc.; and market regions – namely, North America, Latin America, Europe (including Russia), Asia Pacific and China. The total market for nano-enabled packaging for pharma is $3.8 billion in 2009, which is expected to grow to $8.1 billion by 2014, at a compound annual growth rate (CAGR) of 16.48% from 2009 to 2014. Other major findings of this report are: ·        The U.S. and Europe will remain the largest consumers of pharmaceutical packaging, as their advanced drug-producing sectors introduce new therapies with specialized packaging needs. ·        The North America market for nano-enabled packaging in pharma will grow from $1.08 billion in 2008 to $2.03 billion by 2014. The European market will grow from $1.15 billion in 2008 to $1.46 billion in 2014. ·        Japan continues to have the major share of the Asia Pacific market (65%), but its share is expected to decrease as India evolves into a fast-growing pharmaceutical packaging market as drug-producing sectors are upgraded and diversified, especially in the area of generic drugs. China’s growth opportunities will be among the strongest, based on rapidly expanding pharmaceutical manufacturing capabilities there and the phasing-in of a government program designed to upgrade the quality and integrity of nationally produced medicines.